Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Glucagon-like Peptide-1 (GLP-1) on Cognitive and Non-cognitive Function in Human

NCT03414333 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.

NCT NCT03414333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Glucagon-like Peptide-1 (GLP-1) on Cognitive and Non-cognitive Function in Human
Lead sponsor
University of Pisa
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2016
Completion date
June 30, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative brain disorder, glucose metabolism disorders, obesity